Involvement of protein kinase C and nitric oxide in the modulation by insulin-like growth factor-I of glutamate-induced GABA release in the cerebellum

被引:21
作者
CastroAlamancos, MA
Arevalo, MA
TorresAleman, I
机构
[1] CSIC, INST CAJAL, MOLEC NEUROENDOCRINOL LAB, E-28002 MADRID, SPAIN
[2] CSIC, INST CAJAL, PSYCHOBIOL LAB, E-28002 MADRID, SPAIN
[3] CSIC, INST CAJAL, MACROMOLEC CORE SERV, E-28002 MADRID, SPAIN
[4] CSIC, INST CAJAL, LAB CELLULAR, E-28002 MADRID, SPAIN
关键词
insulin-like growth factor I; protein kinase C; nitric oxide; cerebellum; GABA; long-term depression;
D O I
10.1016/0306-4522(95)00472-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Insulin-like growth factor-I elicits a long-term depression of the glutamate-induced GABA release in the adult rat cerebellum that lasts at least several hours, We studied whether protein kinase C and nitric oxide may be involved in this effect of insulin-like growth factor-I on GABA release since both signalling pathways have been implicated in other forms of neuromodulation in the cerebellum, By using microdialysis in the adult rat cerebellum, we found that either an inhibitor of protein kinase C (staurosporine) or of nitric oxide synthase (Nw-nitro-L-arginine methyl ester) counteracted the long-term, but not the acute effects of insulin-like growth factor-I on glutamate-induced GABA release, On the contrary, when either an activator of protein kinase C (phorbol ester), or an nitric oxide donor (L-arginine), were given with glutamate, they mimicked only the acute effects of insulin-like growth factor-I on glutamate-induced GABA release, Finally, when both protein kinase C and nitric oxide-synthase were simultaneously inhibited by conjoint administration of staurosporine and Nw-nitro-L-arginine methyl ester, a complete blockage of both the short and the long-term effects of insulin-like growth factor-I on GABA release was obtained, These results, indicate that: (i) activation by insulin-like growth factor-I of either the protein kinase C or nitric oxide-signalling pathways is sufficient for the short-term inhibition of glutamate-induced GABA release; and (ii) simultaneous activation of both the protein kinase C and the nitric oxide signalling pathways is necessary for insulin-like growth factor-I to induce a long-term depression of GABA responses to glutamate. Thus, long-term depression of glutamate-induced GABA release by insulin-like growth factor-I in the cerebellum is mediated by simultaneous activation of both protein kinase C and nitric oxide-signalling pathways.
引用
收藏
页码:843 / 847
页数:5
相关论文
共 50 条
  • [21] Serum concentrations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in patients with chronic hepatitis
    Okan, A
    Çömlekçi, A
    Akpmar, H
    Okan, I
    Yesil, S
    Tankurt, E
    Simsek, I
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (11) : 1212 - 1215
  • [22] Expression of Insulin-like Growth Factor Binding Protein-3 and Regulation of the Insulin-like Growth Factor-I Axis in Pig Testis
    Park, Hyun-Jung
    Lee, Won-Young
    Chai, Seung-Yeon
    Woo, Jae-Seok
    Chung, Hak-Jae
    Park, Jin-Ki
    Song, Hyuk
    Hong, Kwonho
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2018, 23 (03) : 278 - 285
  • [23] Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin
    Watanabe, Shin
    Tamura, Toshihiro
    Ono, Koh
    Horiuchi, Hisanori
    Kimura, Takeshi
    Kita, Toru
    Furukawa, Yutaka
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (11) : 1214 - 1222
  • [24] Associations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 with bone quality in the general adult population
    Boeker, J.
    Voelzke, H.
    Nauck, M.
    Hannemann, A.
    Friedrich, N.
    CLINICAL ENDOCRINOLOGY, 2018, 88 (06) : 830 - 837
  • [25] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer
    Holdaway, IM
    Mason, BH
    Lethaby, AE
    Singh, V
    Harvey, VJ
    Thompson, PI
    Evans, BD
    ANZ JOURNAL OF SURGERY, 2003, 73 (11) : 905 - 908
  • [26] Glucose metabolism, insulin-like growth factor-I, and insulin-like growth factor-binding protein-1 after alcohol withdrawal
    Paassilta, M
    Kervinen, K
    Kesäniemi, YA
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1999, 23 (03) : 471 - 475
  • [27] Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in children with insulin-dependent diabetes mellitus
    Cinaz, P
    Kendirci, M
    Kurtoglu, S
    Gokcora, N
    Buyan, N
    Yavuz, I
    Demir, A
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1996, 9 (04) : 475 - 482
  • [28] Insulin-like growth factor-I and insulin-like growth factor binding protein-3 during maintenance chemotherapy of acute lymphoblastic leukemia in children
    Schmiegelow, M
    Hertz, H
    Schmiegelow, K
    Holm, K
    Müller, J
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (04) : 268 - 273
  • [29] Serum Concentrations of Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-2 and-3 in Eight Hoofstock Species
    Govoni, Kristen E.
    Goodman, Danielle
    Maclure, Rebecca M.
    Penfold, Linda M.
    Zinn, Steven A.
    ZOO BIOLOGY, 2011, 30 (03) : 275 - 284
  • [30] Effect of protein restriction on messenger RNA of insulin-like growth factor-I and insulin-like growth factor-binding proteins in liver of ovariectomized rats
    Higashi, Y
    Takenaka, A
    Takahashi, SI
    Noguchi, T
    BRITISH JOURNAL OF NUTRITION, 1998, 79 (05) : 447 - 453